These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inflammatory myopathies--a review of newly diagnosed patients (2004-2008) in the Counties Manukau region. Gupta R; Gow PJ N Z Med J; 2013 Mar; 126(1370):89-95. PubMed ID: 23474516 [TBL] [Abstract][Full Text] [Related]
3. Clinical spectrum of inflammatory myositis in South India--a ten year study. Porkodi R; Shanmuganandan K; Parthiban M; Madhavan R; Rajendran P J Assoc Physicians India; 2002 Oct; 50():1255-8. PubMed ID: 12568209 [TBL] [Abstract][Full Text] [Related]
4. Inclusion body myositis: clinical and pathological boundaries. Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577 [TBL] [Abstract][Full Text] [Related]
5. [Therapeutic strategies in idiopatic inflammatory myopathies]. Chakour R; Leimgruber A; Bart PA; Spertini F Rev Med Suisse; 2009 Apr; 5(199):812-8. PubMed ID: 19441746 [TBL] [Abstract][Full Text] [Related]
6. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients. Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419 [TBL] [Abstract][Full Text] [Related]
7. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Chahin N; Engel AG Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720 [TBL] [Abstract][Full Text] [Related]
9. Necrotising myopathy, an unusual presentation of a steroid-responsive myopathy. Bronner IM; Hoogendijk JE; Wintzen AR; van der Meulen MF; Linssen WH; Wokke JH; de Visser M J Neurol; 2003 Apr; 250(4):480-5. PubMed ID: 12700915 [TBL] [Abstract][Full Text] [Related]
10. [Dermatomyositis and polymyositis: clinical aspects and treatment]. Hachulla E Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087 [TBL] [Abstract][Full Text] [Related]
11. Retrospective study of polymyositis in Auckland over 10 years. Ogle S N Z Med J; 1980 Dec; 92(673):433-5. PubMed ID: 6937784 [TBL] [Abstract][Full Text] [Related]
16. Long-term observational study of sporadic inclusion body myositis. Benveniste O; Guiguet M; Freebody J; Dubourg O; Squier W; Maisonobe T; Stojkovic T; Leite MI; Allenbach Y; Herson S; Brady S; Eymard B; Hilton-Jones D Brain; 2011 Nov; 134(Pt 11):3176-84. PubMed ID: 21994327 [TBL] [Abstract][Full Text] [Related]
17. Cyclosporin A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review. Qushmaq KA; Chalmers A; Esdaile JM J Rheumatol; 2000 Dec; 27(12):2855-9. PubMed ID: 11128676 [TBL] [Abstract][Full Text] [Related]
18. Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging. Allanore Y; Vignaux O; Arnaud L; Puéchal X; Pavy S; Duboc D; Legmann P; Kahan A Ann Rheum Dis; 2006 Feb; 65(2):249-52. PubMed ID: 16410529 [TBL] [Abstract][Full Text] [Related]
19. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies. Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672 [TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome. Johnson RW; Williams FM; Kazi S; Dimachkie MM; Reveille JD Arthritis Rheum; 2003 Apr; 49(2):172-8. PubMed ID: 12687507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]